ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions
Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 938
    C1q Is Mandatory for Disease Development in Experimental Arthritis and Expression of Its Receptors Correlates with Disease Activity in Patients
  • Abstract Number: 2798
    C5orf30 a Novel Regulator of Inflammation and Tissue Damage in Rheumatoid Arthritis
  • Abstract Number: 1462
    Cadherin-11 mRNA Expression in the Peripheral Blood of Rheumatoid Arthritis Patients As a Marker of Active Polyarthritis
  • Abstract Number: 528
    Calcium-Calcineurin-NFAT Signaling Pathway Regulates AQP5 Expression in Primary Salivary Gland Acinar Cells
  • Abstract Number: 2988
    Calgranulin Levels Are Elevated in Spondyloarthritis and Reflect the Presence of Acute Microscopic Gut Inflammation
  • Abstract Number: 2926
    Calprotectin Serum Levels Reflect Residual Inflammatory Activity in Patients with Rheumatoid Arthritis and Psoriatic Arthritis on Clinical Remission or Low Disease Activity Undergoing TNF-Antagonists Therapy
  • Abstract Number: 2846
    CaMK4 Inhibition Ameliorates the Development of Th17 Driven Inflammatory Diseases By Preventing Recruitment of IL-17 Producing Cells to Target Organs
  • Abstract Number: 1875
    Can Allopurinol Survival Impact Reverse Depending on Patients’ Characteristics? a Propensity-Score-Based Subgroup Analysis
  • Abstract Number: 1868
    Can DAS 28 at 3 Months after the 1st Biologic Therapy Predict Subsequent Sustainable Clinical Remission in Polyarticular Juvenile Idiopathic Arthritis Patients?
  • Abstract Number: 402
    Can GP88 (Progranulin) be Used As a Biomarker for the Diagnosis and Therapy Evaluation of Rheumatoid Arthritis?
  • Abstract Number: 3007
    Can Knee Pain be Prevented through Diet and Exercise Among Those at High Risk?  the Look Ahead Study
  • Abstract Number: 1490
    Can Tumor Necrosis Factor Inhibitors Protect Rheumatoid Arthritis Patients from Osteoporosis? Impact of Tumor Necrosis Factor Inhibitors on Bone Mineral Density and Bone Remodeling Markers
  • Abstract Number: 138
    Can Ultrasonography of Peripheral Entheses Play a Role in the Diagnosis and Understanding of Diffuse Idiopathic Skeletal Hyperostosis (DISH)?
  • Abstract Number: 157
    Can We Diagnose Acute Gout without Joint Aspiration? Results of a Prospective Study of 112 Patients Presenting with Acute Arthritis
  • Abstract Number: 1097
    Can We Help Identify Learning Disabilities in Fibromyalgia Patients?
  • Abstract Number: 120
    Can We Use Ultrasound to Identify Rheumatoid Arthritis Patients in Remission Who Cannot Taper Their Medication?
  • Abstract Number: 2291
    Canakinumab in Biologic-naïve Versus Previously Biologic-Exposed Systemic Juvenile Idiopathic Arthritis Patients: Efficacy Results from a 12 Week Pooled Post Hoc Analysis
  • Abstract Number: 159
    Canakinumab in Frequently Flaring Gouty Arthritis Patients, Contraindicated, Intolerant or Unresponsive to non-Steriodal Anti-Inflammatory drugs and/or Colchicine: Safety and Efficacy Results from Long Term Follow-up
  • Abstract Number: 1232
    Canakinumab Therapy in Patients with Familial Mediterranean Fever
  • Abstract Number: 2298
    Canakinumab Treatment Shows Maintained Efficacy in Systemic Juvenile Idiopathic Arthritis (SJIA) Patients at Individual Patient Level: An Analysis of 12 Week Pooled Data
  • Abstract Number: 833
    Canakinumab Use in Patients with Cryopyrin-Associated Periodic Syndrome: Interim Safety and Efficacy Results from Beta-Confident Registry
  • Abstract Number: 853
    Cancer Incidence in TNF Inhibitor Treated Patients with Axial Spondyloarthritis and Psoriatic Arthritis – a Study  from the ARTIS and Danbio Registers        
  • Abstract Number: 1768
    Cardiac Involvement in Granulomatosis with Polyangiitis: A Magnetic Resonance Imaging Study of 31 Consecutive Patients
  • Abstract Number: 2641
    Cardiac Magnetic Resonance Imaging in Systemic Lupus Erythematosus
  • Abstract Number: 1322
    Cardiopulmonary Involvement in Juvenile Systemic Sclerosis: Development of Recommendations for Screening and Investigation
  • Abstract Number: 2307
    Cardiovascular Disease Prevention in Rheumatologic Disease: Assessing Screening in a Primary Care Setting
  • Abstract Number: 564
    Cardiovascular Events in Ankylosing Spondylitis. an Updated Meta-Analysis
  • Abstract Number: 865
    Cardiovascular Events Prior to or Early after Diagnosis of SLE
  • Abstract Number: 1367
    Cardiovascular Morbidity and Associated Risk Factors in Spanish Patients with Chronic Inflammatory Rheumatic Diseases Attending Rheumatology Clinics
  • Abstract Number: 1423
    Cardiovascular Risk Estimation in Rheumatoid Arthritis: What Is Missing in Traditional Risk Estimators?
  • Abstract Number: 787
    Cardiovascular Risk Factors and Incident Giant Cell Arteritis
  • Abstract Number: 839
    Cardiovascular Risk with Nsaids in Rheumatoid Arthritis: An Analysis Using Routinely Collected Data
  • Abstract Number: 1359
    Care of Women with Rheumatological Conditions during Family Planning and Pregnancy
  • Abstract Number: 2644
    Carotid Intima-Media Thickness and Plaque in Mexican Mestizos with Systemic Lupus Erythematosus: A Case-Control Study
  • Abstract Number: 2080
    Carryover Effects in Crossover Design Studies in Fibromyalgia and Other Pain Conditions
  • Abstract Number: 2287
    Cartilage Thickness and Bone Health in Children with Juvenile Idiopathic Arthritis
  • Abstract Number: 969
    Caspase-8 Prevents Lung Fibrosis in a Murine SSc-like Disease Model By Preventing Macrophage Differentiation
  • Abstract Number: 1010
    Catecholaminergic-to-Cholinergic Transition of Sympathetic Nerve Fibers in Arthritis and in a Co-Culture System of Sympathetic Ganglia in Vitro
  • Abstract Number: 836
    Categorical Change in 6MWD in Patients with Connective Tissue Disease Associated Pulmonary Arterial Hypertension Receiving Ambrisentan over 3-Years
  • Abstract Number: 2666
    Causes of Stillbirths in Women with SLE
  • Abstract Number: 763
    Caveolin-1 and Peroxisome Proliferator-Activated Receptor Gamma Co-Regulate the Differentiation of Monocytes to Adipocytes and Myofibroblasts in Vivo and in Vitro
  • Abstract Number: 1748
    CCR6+CD4+ Cells Are Counterparts of Follicular T-Cells Supporting Autoantibody Production in Rheumatoid Arthritis
  • Abstract Number: 1863
    CCX168, an Orally Administered C5aR Inhibitor for Treatment of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Abstract Number: 27
    CD115+ Osteoclast Precursors Arise before Clinical Onset of Arthritis and Are Regulated By Proinflammatory Cytokines
  • Abstract Number: 1946
    CD22 Is Required for Formation of Memory B Cell Precursors within Germinal Centers
  • Abstract Number: 2743
    CD27 Is a Key Regulator of T Cell Responses
  • Abstract Number: 2726
    CD28null T Cells from Polymyositis Patients Are Cytotoxic to Autologous Muscle Cells in Vitro Via Perforin-Dependent Mechanisms
  • Abstract Number: 1752
    CD30 As a Target of Aptamers and Delivery Portal for Aptamer-shRNA to Block Th17 Cells
  • Abstract Number: 1751
    CD4 Aptamer-RORγt shRNA Chimera Inhibits IL-17 Synthesis By Human CD4+ T cells
  • Abstract Number: 1744
    CD4+ T Cell Subpopulations in Blood and Synovial Fluid Defined By Differential Expression of Integrins
  • Abstract Number: 1631
    Cell Bound Complement Activation Products and Their Relationship to Disease Activity and Quality of Life Measures in Systemic Lupus Erythematosus
  • Abstract Number: 1924
    Cell Bound Complement Activation Products Have Higher Sensitivity Than Serum C3 and C4 Levels in Systemic Lupus Erythematosus
  • Abstract Number: 80
    Cellular Responses of IL6 Inhibition (Tocilizumab) in Rheumatoid Arthritis Using High-Accuracy Tandem Mass Spectrometry
  • Abstract Number: 2462
    Centrosomal Protein 70kDa Is Down-Regulated By Decoy Receptor 3 in Specifically Rheumatoid Synovial Fibroblasts
  • Abstract Number: 2655
    Cerebral Small Vessel Disease in Systemic Lupus Erythematosus:  Histopathological Study
  • Abstract Number: 2827
    Cervical Spine Fracture and Mortality in Ankylosing Spondylitis
  • Abstract Number: 2359
    CGEN-15001, a Novel Immunomodulatory Fusion Protein of the B7 Family Induces Immune Tolerance and Shows Efficacy in Mouse Models of Rheumatoid Arthritis and Psoriasis
  • Abstract Number: 1903
    Change in 14-3-3η Expression in Early RA Patients Treated with Dmards Corresponds with Change in DAS28 and Good EULAR Responses
  • Abstract Number: 1579
    Change in Weight from Baseline with Apremilast, an Oral Phosphodiesterase 4 Inhibitor: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
  • Abstract Number: 2270
    Changes in Cerebral Blood Flow Velocity in Patients with Familial Mediterranean Fever
  • Abstract Number: 207
    Changes in Knee Compartment Distriubtion of Cartilage Loss and Bone Marrow Lesions over 7 Years: The MOST Study
  • Abstract Number: 2861
    Changes in Knee Kinematics from a 6-Week Hip and Trunk Strengthening Program for Persons with Patellofemoral Osteoarthritis
  • Abstract Number: 1020
    Changes in Peripheral Blood Immune Cell Composition in Osteoarthritis
  • Abstract Number: 2259
    Changes in serum  Soluble RANKL and Osteoprotegerin Levels after Teriparatide Administration in Rheumatic Disease Patients with Glucocorticoid-Induced Osteoporosis
  • Abstract Number: 1964
    Changes in Soluble CD18 Reflect Latency in the Immune System and Predict Radiographic Progression in Early Rheumatoid Arthritis
  • Abstract Number: 2254
    Changes in Subject Characteristics in the Denosumab Pivotal Fracture Trial and Its Extension for up to 8 Years
  • Abstract Number: 1435
    Changes in the Types and Prognoses of Infections Complicated in RA Patients during the Last 15 Years, in Japan.
  • Abstract Number: 604
    Characterisation of Mucosal-Associated Invariant T (MAIT) Cells in Ankylosing Spondylitis Patients
  • Abstract Number: 2806
    Characteristic Phenotype of Peripheral Blood Lymphocytes in Patients with IgG4-Related Disease, Comparing to Primary Sjögren Syndrome and Healthy Controls
  • Abstract Number: 2245
    Characteristics of Conventional Footwear and Their Association with Reductions in Knee Loading with a Flexible Footwear Intervention
  • Abstract Number: 707
    Characteristics of Lupus Patients with Interstitial Lung Disease and Relationship with Jo-1 Antibody
  • Abstract Number: 2124
    Characteristics of Medicare Beneficiaries Travelling Long Distances to Visit a Rheumatologist
  • Abstract Number: 924
    Characteristics of Pain Flares in Knee Osteoarthritis
  • Abstract Number: 256
    Characteristics of Pain in Fabry Disease
  • Abstract Number: 2532
    Characteristics of Primary Sjögren Syndrome in the Black Population of Martinique
  • Abstract Number: 2498
    Characteristics of Responding Versus Non-Responding Moderate Rheumatoid Arthritis Patients Treated with Etanercept Plus Methotrexate
  • Abstract Number: 2415
    Characteristics of Rheumatoid Arthritis Patients Not Receiving Early Initiation of Disease Modifying Therapy
  • Abstract Number: 1065
    Characteristics of Rheumatoid Arthritis Patients with and without Cardiovascular Diseases – Data from the Ontario Best Practice Research Initiative (OBRI)
  • Abstract Number: 2672
    Characteristics of the Reproductive System in Systemic Lupus Erythematosus: A Cross-Sectional Survey with Pair-Matched Controls
  • Abstract Number: 1499
    Characterization of ABT-494, a Second Generation Jak1 Selective Inhibitor
  • Abstract Number: 634
    Characterization of CD4+ T Cell Response and Effects of Regulatory T Cells in Pristane Induced Lupus (PIL)
  • Abstract Number: 434
    Characterization of Lung Inflammation in the Lungs of Early Rheumatoid Arthritis
  • Abstract Number: 1670
    Characterization of Patients with Lupus Nephritis Included in a Large Cohort from the Spanish Society of Rheumatology Registry of Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2107
    Characterization of Social Stigma in Rheumatic Diseases and Correlation with Quality of Life and Medication Adherence
  • Abstract Number: 2978
    Characterization of the Sjögren’s Syndrome Intergenic Non-Coding RNA 1 (SSINCR1)
  • Abstract Number: 1965
    Characterization of the Thyroid Hormone System in Rheumatoid Arthritis
  • Abstract Number: 1961
    Chemokine-like Receptor 1 (CMKLR1) is Expressed on Synoviocytes and Proinflammatory Monocytes in Arthritis and is Predominantly Regulated By β arrestin 2 and G Protein Coupled Receptor Kinase (GRK) 6
  • Abstract Number: 2155
    Chikungunya Fever in Patients Under Biologics
  • Abstract Number: 1869
    Child Pain, Function, and Psychological Outcomes in an Intensive Interdisciplinary Pediatric Pain Rehabilitation Program
  • Abstract Number: 2629
    Childhood-Onset and Adult-Onset Systemic Lupus Erythematosus: Distinctions in an Underserved Ethnic Minority Cohort  
  • Abstract Number: 1295
    Childhood-Onset Systemic Lupus Erythematosus:  Short-Term Treatment Response Rates in Proliferative Lupus Nephritis
  • Abstract Number: 1870
    Children and Parent Satisfaction in the Pediatric Rheumatology Clinic:  Patient Orientated Quality Service Measures
  • Abstract Number: 1437
    Cholesterol Efflux Capacity of HDL and Coronary Atherosclerosis in Rheumatoid Arthritis
  • Abstract Number: 1208
    Cholesterol Loading Induces Neutrophil Extracellular Traps, and Atorvastatin Attenuates This Effect
  • Abstract Number: 1341
    Choosing Not so Wisely: The Tale of Antinuclear Antibody Testing
  • Abstract Number: 1340
    Choosing Subserologies Wisely: An Opportunity for Rheumatologic Healthcare Resource Savings
  • Abstract Number: 251
    Chronic Fatigue Is Associated with Hypoperfusion of Parahippocampal Gyrus
  • Abstract Number: 975
    Chronic Pain Predicts Reduced Physical Activity in a Large Population Cohort Study
  • Abstract Number: 1023
    Chronic PTHrP Treatment Promotes Hypertrophic Differentiation and Inflammatory Gene Expression in Chondrocytes
  • Abstract Number: 2071
    Chronic Widespread Pain Versus Multi-Site Pain: Does the Distribution Matter?
  • Abstract Number: 154
    Cimt in Individuals with Rheumatoid Arthritis Compared to Individuals with Type2 Diabetes
  • Abstract Number: 423
    Circulating Anti-Citrullinated Peptide Antibodies and Cytokines As Biomarkers of Response to Disease-Modifying Antirheumatic Drugs Therapy in Early Rheumatoid Arthritis
  • Abstract Number: 692
    Circulating Anti-Ro/SSA Antibodies Are Associated with the Presence of Severe Mitral Regurgitation in Systemic Lupus Erythematosus
  • Abstract Number: 2020
    Circulating Carotenoids and Subsequent Risk of Rheumatoid Arthritis
  • Abstract Number: 1950
    Circulating CD19+CD38+CD43+  B Cell Subset in SLE Patients Have More Cell Cycle Related Genes Than Healthy Controls
  • Abstract Number: 1215
    Circulating Mediators of Bone Remodeling in Patients with Tophaceous Gout
  • Abstract Number: 1613
    Circulating microRNAs As Candidate Biomarkers of Diagnosis in Systemic Lupus Erythematosus
  • Abstract Number: 1953
    Circulating Plasmablasts from Patients with Systemic Lupus Erythematosus Produce Autoantibodies Reactive to Epstein-Barr Virus
  • Abstract Number: 1897
    Circulating T-Helper Cell- Associated Cytokines and Chemokines in Localized Scleroderma
  • Abstract Number: 361
    Citrullinated 14-3-3η Antibodies Are Specific for Early and Established RA and Are Complementary to ACPA
  • Abstract Number: 449
    Citrullinated-Vimentin-Specific Regulatory T-Cell Responses Associate with ACPA Positive Individuals with Non-Specific Musculoskeletal Symptoms
  • Abstract Number: 448
    Citrulline-Specific Autoimmunity Resides in Quiescent Circulating Memory B Cells in Rheumatoid Arthritis
  • Abstract Number: 2177
    Class a Scavenger Receptor(SR-a)Exacerbated Synovial Fibroblasts-Mediated Inflammation in Rheumatoid Arthritis
  • Abstract Number: 2302
    Classification of Juvenile Spondyloarthropathies According to ASAS Criteria
  • Abstract Number: 1289
    Classification of Osteoarthritis Phenotypes By Metabolomics Analysis
  • Abstract Number: 2186
    Clinical and Immunologic Correlates in Cocaine Users with Serum Anti-Neutrophil Cytoplasmic Antibodies
  • Abstract Number: 1764
    Clinical and Other Differences Observed Between Cocaine Induced and Non-Cocaine Induced Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
  • Abstract Number: 592
    Clinical and Psychological Correlates of Sleep Difficulties in Patients with Spondyloarthropathies Compared to Patients with Rheumatoid Arthritis
  • Abstract Number: 2904
    Clinical and Radiological Features of Down’s Arthropathy
  • Abstract Number: 1256
    Clinical and Temporal Characterization of Anti-Jo-1 Positive Anti-Synthetase Syndrome: Preliminary Results of an International Multicentre Study
  • Abstract Number: 455
    Clinical and Tissue Specificity of Antibodies Against Carbamylated Proteins in Patients with Rheumatoid Arthritis
  • Abstract Number: 1596
    Clinical Characteristics and Outcome of Golimumab Treatment Differs Between Bio-naïve and Patients Previously Exposed to Biologicals. Nationwide Results on Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) and Other Spondylarthritidies (SpA)
  • Abstract Number: 696
    Clinical Characteristics and Outcome of Intestinal Pseudo-Obstruction in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2153
    Clinical Characteristics and Outcomes in Synovial Fluid Culture ̵ Negative Septic Arthritis
  • Abstract Number: 2215
    Clinical Characteristics and Prognosis of Malignancies Associated with Active Myositis
  • Abstract Number: 587
    Clinical Characteristics of Nonradiographic Axial Spondyloarthritis in Korea: A Comparison with Ankylosing Spondylitis
  • Abstract Number: 1537
    Clinical Characteristics of RA Patients Newly Prescribed Tofacitinib Citrate (tofacitinib) in the United States after Food and Drug Administration Approval:  Results from the Corrona US Rheumatoid Arthritis Registry
  • Abstract Number: 1433
    Clinical Characterization of Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
  • Abstract Number: 1114
    Clinical Effectiveness of Exercise and Corticosteroid Injection for Subacromial Impingement Syndrome: A Randomised Controlled Trial
  • Abstract Number: 1488
    Clinical Efficacy of Add-on Iguratimod Therapy in Patients with Active Rheumatoid Arthritis Despite of Methotrexate ~a Multicenter Registry Study~
  • Abstract Number: 1098
    Clinical Efficacy of the High-Concentration Capsaicin Patch for the Treatment of Carpal Tunnel Syndrome
  • Abstract Number: 1907
    Clinical Evaluation of Anti-Aminoacyl tRNA Synthase Antibodies in Rheumatoid Arthritis Patients
  • Abstract Number: 2653
    Clinical Features in Patients with Anti-Triosephosphate Isomerase Antibody-Positive Neuropsychiatric Systemic Lupus Erythematosus
  • Abstract Number: 2303
    Clinical Observation on Ankylosing Spondylitis Patients with Different Phenotypes
  • Abstract Number: 2911
    Clinical Outcomes of Early RA after 7 Years – Does T2T Approach Overcome Delay of Therapy?
  • Abstract Number: 2248
    Clinical Outcomes, Neuropathic Pain and Patient Satisfaction over a 15 Year Period Following Primary Tka: A Repeat-Cross-Sectional Analysis
  • Abstract Number: 2700
    Clinical Phenotype of Systemic Sclerosis Patients with Anti-RNA Polymerase III Antibodies: A New French Cohort, Systematic Review and Meta-Analysis
  • Abstract Number: 1225
    Clinical Presentation and Cytokine Production Abnormalities in a Cohort of Patients Carrying NLRP12 GENE Variants
  • Abstract Number: 562
    Clinical Response and Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Three Years of Adalimumab Therapy
  • Abstract Number: 1557
    Clinical Response in Subjects with Psoriatic Arthritis Following One Year of Treatment with Brodalumab, an Anti-Interleukin-17 Receptor Antibody
  • Abstract Number: 309
    Clinical Significance of Cytokine Profile with Interleukin-18 and -6 in Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 2885
    Clinical Training Opportunities in Two Innovative Ambulatory Resources: The Primary Care Musculoskeletal Clinic and Center of Excellence Multidisciplinary Clinic
  • Abstract Number: 400
    Clinical Utility of 14-3-3η in the Evaluation of Inflammatory Arthritis
  • Abstract Number: 2924
    Clinical Utility of Random Anti-TNF Drug Level Testing and Measurement of Anti-Drug Antibodies on Long-Term Treatment Response in Rheumatoid Arthritis
  • Abstract Number: 596
    Clinical Value of ASDAS Index in Spanish Patients with Ankylosing Spondylitis
  • Abstract Number: 1792
    Clinical-Biological and Pathological Spectrum and Outcome of IgA Vasculitis in Adults: A French Study
  • Abstract Number: 2777
    Clinical-Biological Spectrum and Therapeutic Management of Hypocomplementemic Urticarial Vasculitis: Data from a French Nationwide Study on 57 Patients
  • Abstract Number: 2581
    Clinically Active Non-Radiographic Axial Spondyloarthritis Patients Who Initially Have a Negative MRI and Normal CRP May Develop a Positive MRI or Elevated CRP at a Later Timepoint
  • Abstract Number: 2900
    Clinically Inactive Disease in Juvenile Dermatomyositis – a Proposed Revision to the Pediatric Rheumatology International Trials Organisation Criteria
  • Abstract Number: 686
    Clinicians Approaches to the Management of Background Therapy in SLE Patients in Clinical Remission: Results of an International Survey
  • Abstract Number: 2790
    CMR with Quantitative T2 Mapping in Patients with Active SLE
  • Abstract Number: 902
    Co-Management for Children with JIA: A Survey of Primary Care Providers Regarding Current Practices and Willingness to Provide Services
  • Abstract Number: 1053
    Co-Morbidity Is Associated with Disease Severity in Early Rheumatoid Arthritis
  • Abstract Number: 1194
    Cofilin-1 Is a ROS Sensor in Regulating the NLRP3 Inflammasome
  • Abstract Number: 2654
    Cognitive Function in Systemic Lupus Erythematosus Patients with Past History of Neuropsychiatric Manifestations : A Longitudinal Study
  • Abstract Number: 2650
    Cognitive Impairment in SLE and Non-Criterion Anti-Phospholipid Antibodies
  • Abstract Number: 1825
    Cognitive Performance Scores for the Pediatric Automated Neuropsychological Assessment Metrics in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 2658
    Cognitive Symptoms and Associated Disease and Non-Disease Related Factors in Patients with Systemic Lupus Erythematosus : A Longitudinal Study
  • Abstract Number: 1112
    Cognitive Symptoms in  Fibromyalgia Patients Compared with Rheumatoid Arthritis Patients
  • Abstract Number: 247
    Cognitive Task Related Hypoperfusion of Frontal Gyrus in Patients with Chronic Fatigue
  • Abstract Number: 156
    Colchicine and the Risk of Acute Cardiovascular (CV) Events Among Gout Patients: The New York Department of Veterans Affairs Retrospective Cohort Study
  • Abstract Number: 1356
    Collaboration Between a Third Party Payer and Community Rheumatologists to Create a Clinical Pathway for the Treatment of Rheumatoid Arthritis to Assure Proper Use of Biologics and Quality of Care
  • Abstract Number: 541
    Collagen II Neo-Epitopes in Spondyloarthritis.
  • Abstract Number: 794
    Color Doppler Ultrasonography Findings in Giant Cell Arteritis and Their Relationship with Clinical Manifestations
  • Abstract Number: 123
    Combination with Joint Power Doppler Signals with Anti-Citrullinated Peptide Antibody Predicts Joint Destruction in Rheumatoid Arthritis
  • Abstract Number: 2231
    Combined Chondroitin Sulfate and Glucosamine Is Comparable to Celecoxib for Painful Knee Osteoarthritis. Results from a Multicenter, Randomized, Double-Blind, PHASE IV NON-Inferiority TRIAL 
  • Abstract Number: 601
    Combined Hip Abduction Angle Measured By  Using Iphone Compass Application; A Novel Measurement Tool to Asses Hip Mobility
  • Abstract Number: 638
    Commensal Microbiota Influence Systemic Autoimmune Responses
  • Abstract Number: 2114
    Comorbidity Characteristics of Patients Starting First-Line Acute Gout Agents – Colchicine, NSAID, and Corticosteroids
  • Abstract Number: 1406
    Comorbidity in Rheumatoid Arthritis.  It Is Feasible to Record Concomitant Medical Conditions and Multi-Morbidity in Observational Research Studies. Can This be Extended to Routine Clinical Settings?
  • Abstract Number: 1313
    Comorbidity Patterns in Children with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus: The Childhood Arthritis and Rheumatology Research Alliance Registry
  • Abstract Number: 2823
    Comparable Efficacy with Sarilumab Plus Methotrexate in Biologic-Experienced and Biologic-Naïve  Patients with Moderate-to-Severe Rheumatoid Arthritis from a Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study
  • Abstract Number: 176
    Comparative Cardiovascular (CV) Risk and Outcomes Among Patients with Gout, Osteoarthritis (OA), or Both
  • Abstract Number: 419
    Comparative Dynamics of Rheumatoid Arthritis Disease Activity and Disease Severity Measures Using Rarbis, Ciras and DAS28 in a Population Based Cohort of Patients with RA
  • Abstract Number: 2265
    Comparative Effects of Raloxifene and Bisphosphonate on Bone Mineral Density and Osteoporotic Fracture Outcomes in Rheumatoid Arthritis Patients
  • Abstract Number: 2853
    Comparative Study of Infliximab Versus Adalimumab in Patients with Refractory Uveitis Due to Behçet´s Disease. Multicenter Study of 125 Cases
  • Abstract Number: 2428
    Comparative Study of Rheumatoid Arthritis Disease Activity Indices in Two Populations of Meteor Database
  • Abstract Number: 2400
    Comparing a Tapering Strategy to the Standard Dosing Regimen of TNF Inhibitors in Patients with Rheumatoid Arthritis in Remission or with Low Disease Activity
  • Abstract Number: 1536
    Comparing Abatacept to Adalimumab, Etanercept and Infliximab As First Line Agents in Patients with Rheumatoid Arthritis. Experience from the Rhumadata® Clinical Database and Registry
  • Abstract Number: 2243
    Comparison Between Two Diclofenac Diethylamine Gel Formulations, 1.16% Vs 2.32%: Is It Only Increasing the Strength of the Active Ingredient Enough?
  • Abstract Number: 1119
    Comparison High Intensity Laser Therapy and Wrist Splint in the Treatment of Lateral Epicondylitis
  • Abstract Number: 1428
    Comparison of Application of the European Society Cardiology, Adult Treatment Panel III, and ACC/AHA Guidelines for Cardiovascular Disease Prevention in a French Cohort of Rheumatoid Arthritis
  • Abstract Number: 553
    Comparison of Baseline Extra-Articular Manifestations, Comorbidities, and Long-Term Safety in Patients Treated with Adalimumab for Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
  • Abstract Number: 440
    Comparison of C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) with Estimated Glomerular Filtration Rate (eGFR) in Patients with Rheumatoid Arthritis (RA)
  • Abstract Number: 96
    Comparison of Cardiovascular Risk Factor Management in Patients with RA and Matched Non-RA Patients
  • Abstract Number: 2616
    Comparison of Characteristics of Ankylosing Spondylitis in Association with Familial Mediterranean Fever with Those of Typical Ankylosing Spondylitis
  • Abstract Number: 826
    Comparison of Classification Criteria for Gout Using Monosodium Urate Crystal Identification By a Certified Examiner As the Gold-Standard in a Large Multi-National Study
  • Abstract Number: 547
    Comparison of Clinical and Imaging Characteristics of Axial Psoriatic Arthritis and Axial Spondyloarthritis
  • Abstract Number: 1329
    Comparison of Clinical and Serological Features of Childhood Sjögren Syndrome Based on the Presence or Absence of Parotitis
  • Abstract Number: 1765
    Comparison of Clinical Characteristics of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis By the Serotype Specificity to Myeloperoxidase and Proteinase-3
  • Abstract Number: 791
    Comparison of Clinical Manifestations in Different Histological Subsets of Biopsy-Proven Giant Cell Arteritis
  • Abstract Number: 1766
    Comparison of Clinicopathologically- and Serologically-Based Classification Systems for ANCA-Associated Vasculitis
  • Abstract Number: 2627
    Comparison of Disease Characteristics and Organ Damage in Patients with Juvenile and Adult-Onset Systemic Lupus Erythematosus in Large Cohort from Turkey
  • Abstract Number: 921
    Comparison of Infection Rates in Patients Receiving Denosumab, Denosumab and Biologics and Biologics Alone in a Suburban Rheumatology Clinic
  • Abstract Number: 2424
    Comparison of Medication Use in Rheumatoid Arthritis Patients Between University and Private Settings – Results from Ontario Best Practice Research Initiative
  • Abstract Number: 2807
    Comparison of Outcomes in Septic Arthritis Caused By MRSA and MSSA
  • Abstract Number: 95
    Comparison of Patient Characteristics, Healthcare Costs, and Biologic Persistence Between Patients with Rheumatoid Arthritis Initiating First- or Second-Line Subcutaneous Abatacept, Adalimumab, or Etanercept
  • Abstract Number: 2426
    Comparison of Patient Self-Reported and Physician Reported Rheumatoid Arthritis  Medication Use – Results from the Ontario Best Practices Research Initiative
  • Abstract Number: 2717
    Comparison of PROMIS® survey Between Scleroderma Patients in an Academic Center and Patient-Based Scleroderma Foundations
  • Abstract Number: 2590
    Comparison of Radiographic Damage Score in Ankylosing Spondylitis According to Tumor Necrosis Factor Inhibitor: Observation Study of Korean Spondyloarthropathy Registry (OSKAR) Data
  • Abstract Number: 717
    Comparison of Responsiveness of Lupus Impact Tracker with Lupus Quality of Life to Selena Responder Index
  • Abstract Number: 1599
    Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Pregnancies: Disease Activity, Treatment, and Outcomes
  • Abstract Number: 2688
    Comparison of Systemic Lupus Erythematosus and Healthy Anti-Nuclear Antibody Positive African-Americans Reveals Distinct Differences in T Cell and Progenitor Populations
  • Abstract Number: 3000
    Comparison of Systemic Sclerosis Subsets As Predictors of Mortality and Morbidity
  • Abstract Number: 2365
    Comparison of the Effects of a Pharmaceutical Industry Decision Guide and Decision Aids on Patient Choice to Intensify Rheumatoid Arthritis Therapy with Etanercept
  • Abstract Number: 135
    Comparison of the Ultrasonography Images and Synovial Pathology of the Joints in Patients with Rheumatoid Arthritis Treated with Biological Agents
  • Abstract Number: 1314
    Comparison of the Utility and Validity of Three Scoring Tools to Detect Skin Disease in Patients with Juvenile Dermatomyositis
  • Abstract Number: 1141
    Comparisons of Quality of Life, Resource Use and Physical Functioning in RA Patients Classified As High, Moderate or Low Risk for Rapid Radiographic Progression
  • Abstract Number: 2373
    Compliance in the Rheumatoid Arthritis Comparison of Active Therapies Trial: Triple Vs Etanercept
  • Abstract Number: 473
    Complications of Varicella Zona Virus Infections Are More Frequent in Patients Treated with Biologic Drugs When Combined with Steroids
  • Abstract Number: 461
    Comprehensive Summary of the Efficacy and Safety of Tofacitinib 5mg Twice Daily in Patients with Rheumatoid Arthritis and an Inadequate Response to Disease-Modifying Antirheumatic Drugs
  • Abstract Number: 2553
    Compromised Volumetric Bone Density, Bone Microarchitecture and Bone Strength in Patients with Ankylosing Spondylitis: High-Resolution Peripheral Quantitative Computerized Tomography (HRpQCT) Based Study
  • Abstract Number: 54
    Concordance with the National Osteoporosis Foundation Treatment Guidelines After DXA Result Notification
  • Abstract Number: 2961
    Conditional Analysis of 30 Serum Urate Loci Identifies 25 Additional Independent Effects
  • Abstract Number: 1817
    Connecting Two Pathways through Ca2+ Signaling: NLRP3 Inflammasome Activation Induced By a Hypermorphic PLCG2 Mutation
  • Abstract Number: 2276
    Consensus Statement on the Transition Process from Pediatric Care to Adult Care in Patients with Chronic Inflammatory Rheumatic Diseases with Childhood-Onset
  • Abstract Number: 1890
    Consistent Inhibition of Bone Destruction By Denosumab in Important Subgroups of Japanese Patients with Rheumatoid Arthritis
  • Abstract Number: 2330
    Construct Validity of the Adult Myopathy Assessment Tool in Individuals with Inclusion Body Myositis
  • Abstract Number: 2398
    Continued Participation in a 10-Year Tight Control Treat-to-Target Study in Rheumatoid Arthritis: Why Keep Patients Doing Their BeSt?
  • Abstract Number: 2263
    Continued Zoledronic Acid Use in a Large Healthcare System
  • Abstract Number: 2921
    Contraceptive Factors Are Associated with Serum Antibodies to Citrullinated Protein Antigens in Women at Elevated Risk for Future Rheumatoid Arthritis
  • Abstract Number: L9
    Contrast Enhanced Ultrasonography in Patients Diagnosed with Early Arthritis: A Preliminary Experience
  • Abstract Number: 2784
    Contribution at the Spinal Level of Innate and Adaptive Immunity to the Development of Persistent Post-Inflammatory Mechanical Allodynia in Arthritic Mice
  • Abstract Number: 2090
    Contribution of MTHFR Gene Polymorphisms in Sjogren’s Syndrome Related Lymphomagenesis
  • Abstract Number: 2219
    Contribution of Tripartite Motif Proteins Modulating Membrane Repair to the Pathogenesis of Autoimmune-Mediated Myositis
  • Abstract Number: 1189
    Conventional Magnetic Resonance Imaging (MR) and Hybrid 18F-Fluoride Positron Emission Tomography MRI (18F-F- PET/MRI) of the Spine and the Sacroiliac Joints – a Detailed Description of Pathologic Signals in Patients with Active Ankylosing Spondylitis
  • Abstract Number: 2767
    Core Outcome Domains and Potential Measurement Instruments in  polymyalgia Rheumatica (PMR) Using Omeract Filter 2.0
  • Abstract Number: 2639
    Coronary-Artery Atherosclerosis in Males with Systemic Lupus Erythematosus
  • Abstract Number: 1338
    Correlates of Body Image Dissatisfaction in Patients with Limited and Diffuse Systemic Sclerosis
  • Abstract Number: 229
    Correlates of Heel Bone Mass in Young Adults: The Role of Cholesterol over 20 Years from Childhood to Early Adulthood
  • Abstract Number: 208
    Correlates of Knee Bone Marrow Lesions in Younger Adults
  • Abstract Number: 2497
    Correlation Between Time to  Switch  and Clinical Response Amplitude to  Rituximab in Second  Line  Treatment  in Rheumatoid Arthritis  Patients with Treatment Failure to Tumor Necrosis Factor Inhibitors: 3-Year Data from Repeat Observational Study
  • Abstract Number: 1551
    Correlation of Individual HAQ Questions with Disease Activity Measures in Psoriatic Arthritis: Implications for Instrument Reduction
  • Abstract Number: 2834
    Correlation of Laboratory and Clinical Parameters with British Isles Lupus Assessment Group Response in an Open-Label Extension Study of Epratuzumab in Systemic Lupus Erythematosus
  • Abstract Number: 2813
    Correlation of Morning Stiffness with Measures of Higher Disease Activity in a Large US Registry Population of Rheumatoid Arthritis Patients
  • Abstract Number: 422
    Correlation of RAPID3, DAS28 and CDAI in Disease Activity and Effects of Education Level and Co-Morbid Diseases on This Assesment in RA
  • Abstract Number: 790
    Correlations Between Histopathological Findings and Clinical Manifestations in a Large Monocentric Cohort of Patients with Biopsy-Proven Giant Cell Arteritis
  • Abstract Number: 2143
    Cortical Breaks and Bone Erosions in the Hand Joints: A Cadaver Study Comparing Conventional Radiography with High-Resolution and Micro-Computed Tomography
  • Abstract Number: 925
    Cortical Reorganization after Duloxetine Treatment-Related Pain Decrease in Knee Osteoarthritis
  • Abstract Number: 803
    Corticosteroid-Related Adverse Events in Patients with Giant Cell Arteritis: A Claims-Based Analysis
  • Abstract Number: 688
    Corticosteroids in Early Treatment Pathways in SLE
  • Abstract Number: 155
    Cost-Effectiveness Analysis of HLA-B5801 Genotyping in the Treatment of Gout Patients with Chronic Renal Insufficiency in Korea
  • Abstract Number: 2338
    Cost-Effectiveness and Yield of Different Recruitment Strategies Utilized in an Exercise Trial of Fibromyalgia Patients
  • Abstract Number: 1146
    Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany
  • Abstract Number: 2781
    Cost-Effectiveness of Adding Etanercept Vs. Sulfasalazine and Hydroxychloroquine to Methotrexate Therapy: A Randomized Noninferiority Trial
  • Abstract Number: 2232
    Cost-Effectiveness of Glucosamine, Chondroitin Sulfate, Their Combination, Celecoxib,Non-Selective Non-Steroidal Anti-Inflammatory Drugs, and Placebo in Treating Knee Osteoarthritis
  • Abstract Number: 2235
    Cost-Effectiveness of Long-Term Opioid Use in the Treatment of Knee Osteoarthritis in Older Patients with Multiple Comorbidities  
  • Abstract Number: 98
    Costs of Musculoskeletal Diseases in the United States, 1996-2011: Population Growth, Population Aging, Health Care Utilization, or Prices?
  • Abstract Number: 2709
    Could a Fibroblast-Free Environment Protect the Microcirculation in Systemic Sclerosis? Evidence from Retinal Vascular Imaging Research
  • Abstract Number: 395
    Could Osteoprotegerin and TNF-Related Apoptosis-Inducing Ligand Assessments Help Us to Manage Early Rheumatoid Arthritis? Results from the Espoir Cohort
  • Abstract Number: 296
    Countermeasures Against Methotrexate Intolerance in Juvenile Idiopathic Arthritis Instituted By Parents Show No Effect
  • Abstract Number: 101
    Country of Residence and Its Wealth Determine Disease Activity Levels in RA: Results from Multi-National Study Across 17 Countries (COMORA)
  • Abstract Number: 2329
    Course and Outcome of Rehabilitation Care in Different Rheumatological Diagnosis Groups. a Descriptive Study Using the STAR-Etic Registry
  • Abstract Number: 1511
    COVA322: A Clinical Stage Bispecific TNF/IL-17A Inhibitor for the Treatment of Inflammatory Diseases
  • Abstract Number: 2249
    Criteria for Clinically Important Worsening in Knee and Hip Osteoarthritis
  • Abstract Number: 1315
    Cross-Sectional Evaluation of Hydroxychloroquine (HCQ) Therapy in Children with Juvenile Dermatomyositis (JDM) Enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
  • Abstract Number: 1227
    Cryopyrinopathy with a Myeloid-Specific NLRP3 Mutation
  • Abstract Number: 1966
    CTLA4-Ig (abatacept) Modulate in Vitro the ICAM1 and VEGFR-2 Expression in Human Endothelial Cells
  • Abstract Number: 2144
    Cuantification of Hand Bone Mineral Density By Radiogrammetry and Dual X-Ray Absorptiometry in Early Arthritis Patients
  • Abstract Number: 1525
    Cumulative Clinical  Response in  Rheumatoid  Arthritis Patients with  Rituximab Repeated Courses after Failure to Tumor Necrosis Factor Inhibitors in Routine Clinical Practice  
  • Abstract Number: 1582
    Cumulative Inflammatory Burden Is Independently Associated with Increased Arterial Stiffness in Patients with Psoriatic Arthritis
  • Abstract Number: 1531
    CUT-Off LEVEL of Adalimumab and Prevalence of Antibodies ANTI-Adalimumab in Patients with Ankylosing Spondylitis: Results from a LOCAL Registry
  • Abstract Number: 2775
    Cutaneous Vasculitis Associated with Severe Bacterial Infections. Study of 27 Patients from a Series of 766 Cutaneous Vasculitis
  • Abstract Number: 521
    CXCL13 Serum Levels Is Associated with Lymphoma, High B Cells Markers and Diseases activity  in Primary Sjögren ’s Syndrome Patients
  • Abstract Number: 1704
    CXCL4 Promotes Fibrosis By Increasing Expression of Extracellular Matrix Modifying Factors and By Facilitating Epithelial/Endothelial Mesenchymal Transition
  • Abstract Number: 2465
    Cyclic Phosphatidic Acid (cPA) Suppresses MMP-3, a Disintegrin and Metalloproteinase with Thrombospondin Motifs(ADAMTS)-4, -5 and Stimulates HAS2 Expression in Inflammatory Rheumatoid Synovial Fibroblasts Induced with IL-1β and/or TNF-α
  • Abstract Number: 1640
    Cyclophosphamide Diminishes Plasmablasts and Transitional B Cells and Suppresses Autocrine Production of B Cell Activating Factor of Tumor Necrosis Factor Family (BAFF) in These Cells in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 316
    Cytokines in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome: Tipping the Balance Between Interleukin-18 and Interferon-Gamma
Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies